Our goal is
“Global New Drug Development and Realization of Healthy World based on the core biotechnology."
Global New Drug Research Institute of GENECELLPHARM is a R&D center for disease conquest with up-to-date bio technology and master and doctor level of researchers. We do efforts of developing an innovative new bio drug for overcoming aging diseases and skin diseases since established in 2005 under the goal of ‘Development of Global New Drug and Realization of Healthy Life based on the core bio technology’. Global New Drug Research Institute is composed of Skin Medical Science Research Team, Cell Therapy Product Development Team and Molecular-targeted New Drug Development Team, and does efforts to develop safer and more efficacy molecular-targeted new drug and natural substance drug with global level based on the unique research technology.
“Skin ailment and anti-aging are the areas focused by all generations.”
Skin Science Research Team of Global New Drug Research Institute is the top skin science research institute studying skin differentiation, regeneration and artificial skin based on up-to-date biotechnology. We have published more than 30 articles to international famous academic journals with SCI level. We have strength on securing international trend and future direction of skin science research through active domestic and international patents and academic activities. We have secured core technologies for overcoming skin ailment and skin aging, new anti-aging ingredients and new core target ingredients based on these activities.
“Development of Cell Therapy Products is a customized and innovative medical technology for life extension in the future.”
Cell Therapy Product Development Team of Global New Ingredient Institute progresses innovative endeavor and investment on new candidate drugs in areas having the limitation of modern medicines based on the top infrastructures such as global level of stem cell technology, tissue technology, the best animal model, tracing technology of cell therapy, imaging technology and up-to-date equipment. We progress development of core technology related to autologous stem cell therapy for overcoming degenerative diseases such as arthritis, hair follicle self-cloning technology for overcoming hair loss, and personal customized artificial skin for overcoming wound healing through finding features of stem cell, exact differentiation and function control research, based on our own unique research and original technology.
“Molecular-targeted new drug suggests the most exact solution to the future new drug.”
Molecular-targeted New Drug Development Team of Global New Drug Institute has the top level of researchers with more than 20 year experience in the related areas. We do efforts to search applying point of molecular and to produce candidate for new drug in order to overcome 4 aging diseases. We developed the specific disease targeted molecular substance discovering system in short time and simultaneously at the first in the world. We succeeded to discover new target molecular for tumor and anti-aging by utilizing this technology. We will bring development of molecular-targeted new drug for 4 aging diseases (tumor, blood vessel disease, skin disease, diabetes and obesity) forward based on our team’s high flyness and professionalism. Furthermore, we do efforts to develop effective and safe targeted new drug in the future by discovering new molecular-targeted substances and natural substances for overcoming aged complex and chronic diseases.